<DOC>
	<DOCNO>NCT02223286</DOCNO>
	<brief_summary>The purpose study understand use Corus® CAD clinical decision make process patient underwent evaluation chest pain anginal equivalent symptom . Specifically , good understand whether use assay clinical decision making result change noninvasive diagnostic test order diagnostic yield additional test order and/or invasive angiography .</brief_summary>
	<brief_title>Understanding Clinician Utilization - Cardiology</brief_title>
	<detailed_description>Atherosclerotic coronary artery disease ( CAD ) common cause morbidity mortality worldwide . CAD affect 16.5 million person US . Diagnosing CAD straightforward pose enormous burden health care system . The common symptom CAD chest pain ( angina ) , however , 10 % -30 % chest pain related symptom due CAD . Though several diagnostic test CAD ( e.g. , coronary angiography , stress testing , nuclear myocardial perfusion imaging ( MPI ) ) , limitation , include invasiveness , safety risk ( e.g. , bleeding , radiation exposure ) , expense , lack accuracy , subjectivity evaluation interpretation finding , lack availability geographic region . Recent scientific finding demonstrate multiple gene activate circulate blood cell patient CAD . A gene expression test detects activate and/or deactivate gene could therefore serve tool aid diagnosis CAD . The Corus® CAD test ( henceforth , `` Corus CAD '' ) validate quantitative vitro diagnostic test , perform single Clinical Laboratory Improvement Amendments ( CLIA ) laboratory CardioDx , Inc. , use gene expression level 23 gene peripheral blood specimen assess likelihood subject least 50 % coronary artery stenosis . Corus CAD incorporate expression level gene , use validate algorithm weighted function , generate quantitative score indicate use stable patient typical atypical symptom suggestive CAD ( e.g. , chest pain , shortness breath , heartburn , fatigue exertion ) . The test non-invasive ( involve simple venipuncture ) , result evaluate one laboratory , minimal potential variability analysis finding .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Symptoms suggestive CAD , accord opinion site clinician 2 . Age &gt; = 21 year 1 . History myocardial infarction ( MI ) 2 . History high risk unstable angina , systemic infection systemic inflammatory condition 3 . Current MI acute coronary syndrome 4 . Current New York Heart Association ( NYHA ) class III IV congestive heart failure symptoms 5 . Known/documented CAD 6 . History/current Diabetes Mellitus 7 . Taking steroid , immunosuppressive agent , chemotherapeutic agent , time chest pain presentation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>